Fujian Haixi Pharmaceuticals Co., Ltd.

This study is testing a new drug called C019199 combined with an existing immunotherapy (sintilimab) for people with advanced solid tumors that have stopped responding to standard treatments. The first part aims to find a safe dose, and the second part will see how well the combi…